Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
3.
J Med Life ; 7(1): 94-9, 2014 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-24653766

RESUMEN

INTRODUCTION: A long term, retrospective study was performed aiming to outline a critical comparison concerning the efficacy, safety and durability of the bipolar plasma vaporization (BPV), standard monopolar transurethral resection (TUR) and "cold-knife" "star" transurethral incision (TUI) in secondary bladder neck sclerosis (BNS) cases. MATERIALS & METHODS: Of the 126 patients included in the trial based on maximum flow rate (Qmax) below 10 mL/s and International Prostate Symptom Score (IPSS) over 19, classical resection was performed in 46 cases, "cold-knife" TUI in 37 cases and bipolar vaporization in 43 patients. The evaluation protocol comprised IPSS, QoL (quality of life) score, Qmax and PVR (post-voiding residual urinary volume) assessment performed at 1, 3, 6, 12, 18 and 24 months after the initial intervention. RESULTS: Significant intraoperative complications (capsular perforation - 8.7%; bleeding - 4.3%) occurred secondary to monopolar resection. "Star" TUI was the fastest technique, followed by plasma-button vaporization (7.2 and 11.4 versus 16.5 minutes). BPV and TUI patients benefitted from the shortest catheterization periods (0.75 and 1 versus 2.0 days) and hospital stays (1.0 and 1.25 versus 2.0 days). Immediate postoperative adverse events consisted of hematuria (6.5% of the TUR cases) and acute urinary retention (8.1% of the TUI group). Significantly higher long term BNS recurrence rates requiring re-treatment were established in the TUI (18.7%) and TUR (12.8%) series by comparison to BPV (5.4%). Among patients that completed the follow-up protocol, equivalent IPSS, QoL, Qmax and PVR features were determined in the 3 study arms. CONCLUSIONS: The plasma vaporization approach was confirmed as a successful match to conventional TUR and "cold-knife" TUI in terms of surgical safety profile, postoperative recovery, therapeutic durability and urodynamic and symptom score parameters.


Asunto(s)
Cistotomía/métodos , Esclerosis/cirugía , Resección Transuretral de la Próstata/efectos adversos , Ureteroscopía/métodos , Enfermedades de la Vejiga Urinaria/cirugía , Medicina Basada en la Evidencia , Humanos , Calidad de Vida , Estudios Retrospectivos , Esclerosis/etiología , Enfermedades de la Vejiga Urinaria/etiología , Volatilización
4.
Epilepsy Res ; 90(1-2): 21-7, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20307957

RESUMEN

OBJECTIVE: The seizure network may be different between temporal lobe epilepsy with hippocampal sclerosis (TLE+HS) and without HS (TLE-HS). Chronic seizure activity may alter the diffusion properties of a seizure network. The thalamus is known to have an anatomical connection to the medial temporal area and to play a role in seizure modulation. This study aimed to evaluate differences in thalamic changes between TLE+HS and TLE-HS with diffusion tensor imaging (DTI). METHODS: Nine patients with TLE+HS and nine patients with TLE-HS were included in the study. All patients underwent surgery with good seizure outcomes. Hippocampal sclerosis was verified pathologically. Sixteen right-handed, normal subjects were enrolled as controls. DTI was acquired using 3.0 T MRI. The mean diffusivity (MD) and fractional anisotropy (FA) were calculated in the center of the bilateral thalamus with the DTIstudio program. RESULTS: The MD of bilateral thalami increased in both TLE groups compared to controls (p<0.05), while FA values did not differ from controls. The MD of the thalamus ipsilateral to the epileptogenic side was higher in the TLE+HS group than in the TLE-HS group (p=0.007). Onset age, seizure duration, seizure frequency and total seizure number were not correlated with FA and MD changes (p>0.05). CONCLUSION: Bilateral thalamic diffusion properties are altered in temporal lobe epilepsy. The presence of hippocampal sclerosis enhances the change ipsilaterally.


Asunto(s)
Imagen de Difusión Tensora , Epilepsia del Lóbulo Temporal/patología , Hipocampo/patología , Tálamo/fisiopatología , Adulto , Anisotropía , Mapeo Encefálico , Epilepsia del Lóbulo Temporal/complicaciones , Femenino , Lateralidad Funcional , Humanos , Masculino , Esclerosis/etiología , Esclerosis/patología , Estadísticas no Paramétricas , Adulto Joven
5.
Clin Neurophysiol ; 119(6): 1310-9, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18381250

RESUMEN

OBJECTIVE: The role of the hippocampus in sensory gating is unresolved as yet. The current study was conducted in order to examine the effects of hippocampal lesions on the function of auditory sensory gating. METHODS: Epilepsy patients with unilateral and bilateral hippocampal sclerosis (HS) were investigated. Auditory-evoked potentials (AEPs) were recorded by multichannel scalp EEG in a double-click experiment. Gating was defined as the response decrease of the AEP components from 1st to 2nd click. RESULTS: Diagnosis (left vs. right vs. bilateral HS) did not affect the amplitudes or gating of the P50, N100 or P200 components. However, diagnosis had an impact on the topography of the N100 component after its peak maximum: In right HS patients, the N100 was left-lateralized, while it was nearly symmetrically distributed in patients with left HS and right lateralized in patients with bilateral HS. Besides the N100, the topography of the P200 component was affected by diagnosis. CONCLUSIONS: Findings suggest that auditory activity, as reflected in the N100 and P200 components, is modulated by the hippocampus, but not sensory gating in its classical definition. SIGNIFICANCE: Deficits in P50 gating in schizophrenia are unlikely to be explained by hippocampal deficits.


Asunto(s)
Epilepsia/patología , Epilepsia/fisiopatología , Potenciales Evocados Auditivos/fisiología , Lateralidad Funcional/fisiología , Hipocampo/patología , Esclerosis/etiología , Estimulación Acústica/métodos , Adolescente , Adulto , Mapeo Encefálico , Electroencefalografía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Tiempo de Reacción/fisiología , Esclerosis/patología , Análisis Espectral
6.
Radiother Oncol ; 79(1): 45-51, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16546280

RESUMEN

BACKGROUND AND PURPOSE: Tissue hardness (induration), pain and tenderness are common late adverse effects of curative radiotherapy for early breast cancer. The purpose of this study was to test the efficacy of IH636 grape seed proanthocyanidin extract (GSPE) in patients with tissue induration after high-dose radiotherapy for early breast cancer in a double-blind placebo-controlled randomised phase II trial. PATIENTS AND METHODS: Sixty-six eligible research volunteers with moderate or marked breast induration at a mean 10.8 years since radiotherapy for early breast cancer were randomised to active drug (n = 44) or placebo (n = 22). All patients were given grape seed proanthocyanidin extract (GSPE) 100 mg three times a day orally, or corresponding placebo capsules, for 6 months. The primary endpoint was percentage change in surface area (cm(2)) of palpable breast induration measured at the skin surface 12 months after randomisation. Secondary endpoints included change in photographic breast appearance and patient self-assessment of breast hardness, pain and tenderness. RESULTS: At 12 months post-randomisation, > or =50% reduction in surface area (cm(2)) of breast induration was recorded in 13/44 (29.5%) GSPE and 6/22 (27%) placebo group patients (NS). At 12 months post-randomisation, there was no significant difference between treatment and control groups in terms of external assessments of tissue hardness, breast appearance or patient self-assessments of breast hardness, pain or tenderness. CONCLUSIONS: The study failed to show efficacy of orally-administered GSPE in patients with breast induration following radiotherapy for breast cancer.


Asunto(s)
Antioxidantes/uso terapéutico , Neoplasias de la Mama/radioterapia , Mama/efectos de la radiación , Extractos Vegetales/uso terapéutico , Proantocianidinas/uso terapéutico , Radioterapia Adyuvante/efectos adversos , Administración Oral , Anciano , Mama/patología , Neoplasias de la Mama/patología , Método Doble Ciego , Femenino , Extracto de Semillas de Uva , Humanos , Persona de Mediana Edad , Placebos , Esclerosis/tratamiento farmacológico , Esclerosis/etiología , Encuestas y Cuestionarios , Insuficiencia del Tratamiento
7.
Eksp Klin Farmakol ; 62(2): 16-8, 1999.
Artículo en Ruso | MEDLINE | ID: mdl-10340121

RESUMEN

Rats with experimental cardiosclerosis detected 21 days after embolization of the coronary arteries were subjected to early chronic perindopril administration (per os, 2 mg/kg once a day on days 2-20 after immobilization. As a result, the number of scars reduced, focal cardiosclerosis, dystrophy and hypertrophy of the cardiomyocytes were less pronounced, and the content of cellular glycogen increased. The cardioprotective effect was attended with a normalizing influence on the renin-angiotensin system parameters which were significantly changed after experimental damage to the myocardium: perindopril restored angiotensin I clearance and the level of angiotensin II production in the lungs.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Cardiomiopatías/tratamiento farmacológico , Fármacos Cardiovasculares/uso terapéutico , Indoles/uso terapéutico , Miocardio/patología , Animales , Cardiomiopatías/sangre , Cardiomiopatías/etiología , Cardiomiopatías/patología , Trombosis Coronaria/sangre , Trombosis Coronaria/complicaciones , Trombosis Coronaria/etiología , Trombosis Coronaria/patología , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Masculino , Perindopril , Distribución Aleatoria , Ratas , Ratas Wistar , Sistema Renina-Angiotensina/efectos de los fármacos , Esclerosis/sangre , Esclerosis/tratamiento farmacológico , Esclerosis/etiología , Esclerosis/patología
8.
Oral Surg Oral Med Oral Pathol ; 70(4): 414-9, 1990 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-2216378

RESUMEN

Diffuse sclerosing osteomyelitis of the mandible is a disease of unknown etiology. The clinical and radiographic findings suggest an infectious origin, but bacteriologic and histologic findings do not support this concept. Analysis of clinical symptoms, localization of the condition, and posttreatment findings in a group of 27 patients suggest a chronic tendoperiostitis due to muscular overuse as an etiologic factor in diffuse sclerosing osteomyelitis of the mandible. This hypothesis was supported by the initial results of muscle relaxation treatment in 13 of these patients.


Asunto(s)
Enfermedades Mandibulares/etiología , Músculos Masticadores/fisiopatología , Músculos del Cuello/fisiopatología , Osteomielitis/etiología , Adolescente , Adulto , Anciano , Niño , Femenino , Humanos , Masculino , Enfermedades Mandibulares/terapia , Persona de Mediana Edad , Contracción Muscular , Osteomielitis/terapia , Periostitis/complicaciones , Terapia por Relajación , Esclerosis/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA